1324 related articles for article (PubMed ID: 8982753)
61. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel.
Rogers PA; Au CL; Affandi B
Hum Reprod; 1993 Sep; 8(9):1396-404. PubMed ID: 8253925
[TBL] [Abstract][Full Text] [Related]
62. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
[TBL] [Abstract][Full Text] [Related]
63. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
Hickey M; Dwarte D; Fraser IS
Hum Reprod; 2000 Jul; 15(7):1509-14. PubMed ID: 10875858
[TBL] [Abstract][Full Text] [Related]
64. Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies.
Subakir SB; Setiadi E; Affandi B; Pringgoutomo S; Freisleben HJ
Toxicology; 2000 Aug; 148(2-3):173-8. PubMed ID: 10962136
[TBL] [Abstract][Full Text] [Related]
65. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
[TBL] [Abstract][Full Text] [Related]
66. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
Hickey M; Fraser IS
Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
[TBL] [Abstract][Full Text] [Related]
67. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
Zheng SR; Zheng HM; Qian SZ; Sang GW; Kaper RF
Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
[TBL] [Abstract][Full Text] [Related]
68. Effectiveness of Norplant implants among Thai women in Bangkok.
Chompootaweep S; Kochagarn E; Sirisumpan S; Tang-usaha J; Theppitaksak B; Dusitsin N
Contraception; 1996 Jan; 53(1):33-6. PubMed ID: 8631187
[TBL] [Abstract][Full Text] [Related]
69. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
Landgren BM; Johannisson E; Xing S; Aedo AR; Diczfalusy E
Contraception; 1985 Dec; 32(6):581-601. PubMed ID: 3937664
[TBL] [Abstract][Full Text] [Related]
70. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
[TBL] [Abstract][Full Text] [Related]
71. NORPLANT contraceptive implants advancing.
Segal SJ
Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
[TBL] [Abstract][Full Text] [Related]
72. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
Bergquist C; Nillius SJ; Wide L; Lindgren A
Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
[TBL] [Abstract][Full Text] [Related]
73. The measurement of endometrial perfusion in norplant users: a pilot study.
Hickey M; Carati C; Manconi F; Gannon BJ; Dwarte D; Fraser IS
Hum Reprod; 2000 May; 15(5):1086-91. PubMed ID: 10783358
[TBL] [Abstract][Full Text] [Related]
74. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
75. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
76. New contraceptives in the 1990s.
O'Connell BJ
Curr Opin Pediatr; 1995 Aug; 7(4):371-5. PubMed ID: 7581638
[TBL] [Abstract][Full Text] [Related]
77. Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding.
Pritts EA; Ryan IP; Mueller MD; Lebovic DI; Shifren JL; Zaloudek CJ; Korn AP; Darney PD; Taylor RN
J Clin Endocrinol Metab; 2005 Apr; 90(4):2142-7. PubMed ID: 15623808
[TBL] [Abstract][Full Text] [Related]
78. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium.
Charnock-Jones DS; Macpherson AM; Archer DF; Leslie S; Makkink WK; Sharkey AM; Smith SK
Hum Reprod; 2000 Aug; 15 Suppl 3():85-95. PubMed ID: 11041225
[TBL] [Abstract][Full Text] [Related]
79. Precise measurements of intrauterine vascular structures at hysteroscopy in menorrhagia and during Norplant use.
Hickey M; Dwarte D; Fraser IS
Hum Reprod; 1998 Nov; 13(11):3190-6. PubMed ID: 9853879
[TBL] [Abstract][Full Text] [Related]
80. Estradiol plasma levels during long-term treatment with Norplant subdermal implants.
Croxatto HB; Díaz S; Pavez M; Brandeis A
Contraception; 1988 Oct; 38(4):465-75. PubMed ID: 3145171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]